News
- 2024.02.22 RESEARCHES Registration of iPS cell stock (QHJI strain) for clinical use as a U.S. Drug Master File
- 2024.01.18 RESEARCHES CiRA_F and CIRM Sign Agreement for Widespread Use of iPS Cell Stock
- 2023.12.26 RESEARCHES Start of Investigator-Initiated Clinical Study of iPS Cell-Derived Dopaminergic Progenitor Cells for Parkinson's Disease in the United States
-
2023.06.14
RESEARCHES
Provision of HLA Genome-edited iPS Cell Stock for Clinical Use
-
2023.04.11
RESEARCHES
CiRA Foundation Signed Letter of Intent with Transformative Cell Processing Company
-
2023.04.05
RESEARCHES
Provision of a New iPS Cell Line for Clinical Use
- 2023.03.02 RESEARCHES Knowledge Palette and CiRA Foundation Executed a Collaborative Research Contract to Evaluate and Improve Quality of iPS Cells
- 2022.12.27 RESEARCHES Toshiba and the CiRA Foundation Begin Joint Research on Methods for Manufacturing iPS Cells Using Liposome technology
- 2022.12.20 RESEARCHES Thyas Enters into Joint Research Agreement and Exclusive License for Data and Patents of Clinical Manufacturing of iPSC-Derived CAR-NK Cells
-
2022.11.17
RESEARCHES
Update on the iPS Cell Stock at the CiRA Foundation